人乳腺癌患者中类固醇受体及其他预后因素的免疫组织化学定量分析 - Suppr

Suppr

超能文献

Immunohistochemical quantification of steroid receptors and other prognosis factors in human breast cancer patients.

作者信息

Fritz P, Tuczek H V, Offinger B, Schwarzmann P, Schieszl S, Wu X, Kleine B, Blödorn J, Multhaupt H

机构信息

Pathologisches Institut, Robert Bosch Krankenhaus, Stuttgart, Germany.

出版信息

Prog Histochem Cytochem. 1992;26(1-4):146-58. doi: 10.1016/s0079-6336(11)80090-2.

DOI:10.1016/s0079-6336(11)80090-2

PMID:1283015

Abstract

摘要

相似文献

Immunohistochemical quantification of steroid receptors and other prognosis factors in human breast cancer patients.人乳腺癌患者中类固醇受体及其他预后因素的免疫组织化学定量分析

Prog Histochem Cytochem. 1992;26(1-4):146-58. doi: 10.1016/s0079-6336(11)80090-2.

Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques.提高福尔马林固定石蜡切片中各种核内预后标志物免疫组化染色的策略：通过抗原修复技术显示雄激素受体、雌激素受体、孕激素受体、p53蛋白、增殖细胞核抗原和Ki-67抗原。

Hum Pathol. 1994 Mar;25(3):263-70. doi: 10.1016/0046-8177(94)90198-8.

Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer.受体状态、增殖活性与c-erbB2癌蛋白：乳腺癌的免疫细胞化学评估

Ann N Y Acad Sci. 1993 Nov 30;698:167-73. doi: 10.1111/j.1749-6632.1993.tb17205.x.

[Cytosolic concentrations of cathepsin D in 88 infiltrating ductal breast carcinomas having negative estrogen and progesterone receptors. Correlation with other clinical and biological parameters].

Rev Esp Med Nucl. 2001 Jun;20(4):332-3. doi: 10.1016/s0212-6982(01)71967-2.

Correlation between pS2 protein positivity, steroid receptor status and other prognostic factors in breast cancer.乳腺癌中pS2蛋白阳性、类固醇受体状态与其他预后因素之间的相关性。

Int J Biol Markers. 1995 Apr-Jun;10(2):87-93. doi: 10.1177/172460089501000204.

[Value of immunohistochemical determination of receptors, tissue proteases, tumor suppressor proteins and proliferation markers as prognostic indicators in primary breast carcinoma].[免疫组织化学检测受体、组织蛋白酶、肿瘤抑制蛋白和增殖标志物作为原发性乳腺癌预后指标的价值]

Geburtshilfe Frauenheilkd. 1996 Apr;56(4):177-83. doi: 10.1055/s-2007-1022256.

Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer.早期临床淋巴结阴性乳腺癌中的类固醇受体、pS2和组织蛋白酶D

Eur J Cancer. 1994;30A(1):5-11. doi: 10.1016/s0959-8049(05)80008-5.

Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.与组织蛋白酶D、基质溶解素-1、CD44、细胞外基质成分、P53、Rb、C-erbB-2、表皮生长因子受体、类固醇受体含量及增殖情况相比，金属硫蛋白在人乳腺癌中的免疫组织化学定位

Anticancer Res. 1999 May-Jun;19(3A):2133-9.

PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.乳腺癌中PCNA/细胞周期蛋白的表达：其与Ki-67、雌激素受体、孕激素受体免疫染色及临床病理特征的关系

Pathologica. 1993 Jan-Feb;85(1095):47-55.

Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.采用Ventana ES 320自动免疫组织化学染色仪及CAS 200图像分析仪检测236例早期乳腺癌的雌激素和孕激素受体状态：预后意义

J Surg Oncol. 1996 Mar;61(3):177-84. doi: 10.1002/(SICI)1096-9098(199603)61:3<177::AID-JSO3>3.0.CO;2-8.

引用本文的文献

Comparison of different detection methods in quantitative microdensitometry.定量显微密度测定法中不同检测方法的比较

Am J Pathol. 2001 Feb;158(2):407-17. doi: 10.1016/S0002-9440(10)63984-3.

Immunohistochemical detection of microsomal epoxide hydrolase in human synovial tissue.

Histochem J. 1999 Oct;31(10):645-9. doi: 10.1023/a:1003843502831.

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin.肠道P-糖蛋白在地高辛与利福平相互作用中的作用。

J Clin Invest. 1999 Jul;104(2):147-53. doi: 10.1172/JCI6663.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验